Oxatomide in the treatment of atopic dermatitis in breast-fed and very young infants

Minerva Pediatrica

Volumn 53, Issue 4, 2001, Pages 265-269

  Boccazzi, A ^a   Pugni, L ^b   Cesuti, R ^b   Rapuzzi, S ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE

Author keywords

Breast feeding; Dermatitis, atopic; Piperazines, therapeutic use

Indexed keywords

OXATOMIDE;

ARTICLE; ATOPIC DERMATITIS; BLISTER; BREAST FEEDING; CLINICAL ARTICLE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRY SKIN; ERYTHEMA; FEMALE; HUMAN; INFANT; MALE; PAPULE; PRURITUS; SUSPENSION; SYMPTOMATOLOGY;

ANTI-ALLERGIC AGENTS; BREAST FEEDING; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PIPERAZINES;

EID: 0034783748     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Consensus Conference 1990 del Gruppo di Immunologia della SIP. La dermatite atopica nell'infanzia: approccio diagnostico e terapeutico. Riv Immunol All Ped 1991:4-5.
2. rd edition. 1988;(2):1403-28.
3. Buckley C. The management of infantile and childhood atopic dermatitis. J Dermatol Treat 1995;6:243-6.
4. Leung DYM. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic disease. J Allergy Clin Immunol 1995;96(3):302-18.
5. Leung DYM, Hanifin JM, Charlesworth EN. Disease management of atopic dermatitis: a practice parameter. Ann Allergy Asthma Immunol 1997;79(3):197-211.
6. Przybilla B, Eberlein-Konig B, Rueff F. Practical management of atopic eczema. Lancet 1994;343: 1342-6.
7. Cavagni G. Il bambino e l'allergia. Milano: Ed. Sperling & Kupfer, 1997.
8. Oggiano N, Nicora M. L'oxatomide nell'asma bronchiale. Rassegna dei principali dati farmacologici e clinici. Pediatr Oggi Med Chir 1997;17(2):35-48.
9. Stingeni L, Nicora M, Lisi P. Oxatomide in dermatologia: revisione dei principali effetti farmacodinamicie clinici. Ann Ital Dermatol Clin Sper 1998;52:9-21.
10. Benvenuti C, Cavalli E. Farmacovigilanza su oxatomide nel trattamento dell'asma bronchiale allergico. Studio policentrico di confronto tra due schemi posologici su 920 casi. Riv Patol Clin 1995;50(3):167-86.
11. Patella V, De Crescenzo G, Marino O, Spadaro G, Genovese A, Marone G. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells. Int Arch Allergy Immunol 1996;111: 23-9.
12. Paulussen J, Fischer M, Kok-Van Esterik J, Tiemessen R, De Mol N, Janssen L. Influence of the anti-allergic drug oxatomide on the signal transduction mechanism in a mast cell model. Eur J Pharmacol 1996;312: 121-30.
13. Fischer MJE, Paulussen JJC, Roozendaal R, Tiemessen RC, De Mol NJ, Janssen LHM. Relation between effects of a set of anti-allergic drugs on calcium pathways and membrane structure in FcεRI activated signal transduction. Inflamm Res 1996;45:564-73.
14. Hanifin JM, Raika G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980;92: 44-7.
15. Bergonzi F, Mangili G. Trattamento della dermatite atopica con oxatomide sospensione orale nipiologica (2,5 mg/ml). Minerva Pediatr 1997;49:579-87.
16. Duse M, Merlini R, Gardenghi R, Porteri V. L'oxatomide nel trattamento della dermatite atopica. Minerva Pediatr 1998;50:359-65.
17. Capristo AF, Miraglia Del Giudice Jr M, Maiello N, Decimo F. Studio in doppia cecità oxatomide versus placebo nel trattamento delle allergopatie alimentari in età pediatrica. Arch Med Int 1997;49(3-4):49-61.
18. Taskapan MO, Kumar P. Role of staphylococcal superantigens in atopic dermatitis: from colonization to inflammation. Ann Allergy Asthma Immunol 2000;84(1): 3-10.